AG
Artal Group Portfolio holdings
AUM
$930M
This Quarter Return
+5.69%
1 Year Return
-3.57%
3 Year Return
+157.23%
5 Year Return
+160.22%
10 Year Return
+1,359.85%
AUM
$3.88B
AUM Growth
+$3.88B
(+4.9%)
Cap. Flow
+$10.3M
Cap. Flow
% of AUM
0.27%
Top 10 Holdings %
Top 10 Hldgs %
90.38%
Holding
98
New
16
Increased
18
Reduced
14
Closed
4
Top Buys
| 1 |
XLRN
Acceleron Pharma Inc.
XLRN
|
$15.9M |
| 2 |
MetLife
MET
|
$10.6M |
| 3 |
Ionis Pharmaceuticals
IONS
|
$10.1M |
| 4 |
TSRO
TESARO, Inc.
TSRO
|
$7.69M |
| 5 |
Neurocrine Biosciences
NBIX
|
$7.58M |
Top Sells
| 1 |
Incyte
INCY
|
$43.4M |
| 2 |
BLUE
bluebird bio
BLUE
|
$15.7M |
| 3 |
ALXN
Alexion Pharmaceuticals Inc
ALXN
|
$12.1M |
| 4 |
CELG
Celgene Corp
CELG
|
$11.6M |
| 5 |
Alnylam Pharmaceuticals
ALNY
|
$10.3M |
Sector Composition
| 1 | Consumer Staples | 52.04% |
| 2 | Healthcare | 33.12% |
| 3 | Consumer Discretionary | 12.51% |
| 4 | Financials | 0.85% |
| 5 | Industrials | 0.32% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
BUFF
1
DELISTED
Blue Buffalo Pet Products, Inc
BUFF
| $2.01B | 44.65% | 87,460,875 | – | – |
|
2
Lexicon Pharmaceuticals
LXRX
$400M
| $825M | 18.31% | 57,517,977 | – | – |
|
|
WW
3
DELISTED
WW International
WW
| $458M | 10.18% | 29,443,300 | – | – |
|
4
Agios Pharmaceuticals
AGIO
$2.19B
| $43.8M | 0.97% | 750,000 | – | – |
|
|
5
Incyte
INCY
$16.5B
| $43.4M | 0.96% | 325,000 -325,000 | -50% | -$43.4M |
|
6
BioMarin Pharmaceuticals
BMRN
$11.2B
| $28.5M | 0.63% | 325,000 -25,000 | -7% | -$2.19M |
|
7
Alibaba
BABA
$322B
| $27M | 0.6% | 250,000 | – | – |
|
8
Nektar Therapeutics
NKTR
$568M
| $23.5M | 0.52% | 1,000,000 | – | – |
|
|
BLUE
9
DELISTED
bluebird bio
BLUE
| $22.7M | 0.5% | 250,000 -172,536 | -41% | -$15.7M |
|
|
ATH
10
DELISTED
Athene Holding Ltd. Class A Common Shares
ATH
| $22.5M | 0.5% | 450,000 +50,000 | +13% | +$2.5M |
|
|
XLRN
11
DELISTED
Acceleron Pharma Inc.
XLRN
| $19.9M | 0.44% | 750,000 +600,000 | +400% | +$15.9M |
|
|
12
Alnylam Pharmaceuticals
ALNY
$58.5B
| $15.4M | 0.34% | 300,000 -200,000 | -40% | -$10.3M |
|
|
13
Neurocrine Biosciences
NBIX
$13.8B
| $14.1M | 0.31% | 325,000 +175,000 | +117% | +$7.58M |
|
14
Amicus Therapeutics
FOLD
$2.34B
| $13.5M | 0.3% | 1,900,000 +150,000 | +9% | +$1.07M |
|
|
ONC
15
BeOne Medicines Ltd. American Depositary Shares
ONC
$36.4B
| $13.3M | 0.3% | 363,286 +63,286 | +21% | +$2.32M |
|
|
SAGE
16
DELISTED
Sage Therapeutics
SAGE
| $12.4M | 0.28% | 175,000 +25,000 | +17% | +$1.78M |
|
17
ZTO Express
ZTO
$14.6B
| $12.4M | 0.28% | 950,000 -50,000 | -5% | -$655K |
|
18
Ironwood Pharmaceuticals
IRWD
$214M
| $12.2M | 0.27% | 716,879 +200,000 | +39% | +$3.41M |
|
|
ALXN
19
DELISTED
Alexion Pharmaceuticals Inc
ALXN
| $12.1M | 0.27% | 100,000 -100,000 | -50% | -$12.1M |
|
|
HZNP
20
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $11.8M | 0.26% | 800,000 +300,000 | +60% | +$4.43M |
|
|
21
MetLife
MET
$54.1B
| $10.6M | 0.23% | +200,000 | New | +$10.6M |
|
22
Atara Biotherapeutics
ATRA
$84.6M
| $10.3M | 0.23% | 500,000 | – | – |
|
|
KITE
23
DELISTED
Kite Pharma, Inc.
KITE
| $10.2M | 0.23% | 130,000 -120,000 | -48% | -$9.42M |
|
|
24
Ionis Pharmaceuticals
IONS
$6.8B
| $10.1M | 0.22% | +250,000 | New | +$10.1M |
|
|
RDUS
25
DELISTED
Radius Health, Inc.
RDUS
| $9.66M | 0.21% | 250,000 +150,000 | +150% | +$5.8M |
|